Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: A systematic review and meta-analysis of comparative effectiveness

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Wright, Cameron M ^a   Westerkamp, Lenna ^b   Korver, Sarah ^c   Dobler, Claudia C ^d,e  

^a UNIVERSITY OF TASMANIA   (Australia)

^b SPECTRUM HEALTH   (United States)

^c National Tuberculosis Centre   (Nepal)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Adherence; Clinic DOT; Community based DOT; Directly observed therapy; DOT; Tuberculosis

Indexed keywords

ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; DIRECTLY OBSERVED THERAPY; DISEASE SEVERITY; HUMAN; INTERMETHOD COMPARISON; IRAQ; META ANALYSIS; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RURAL POPULATION; SHORT COURSE THERAPY; SOCIAL STATUS; SOUTH AFRICA; SYSTEMATIC REVIEW; TANZANIA; THAILAND; TREATMENT DURATION; TUBERCULOSIS; URBAN POPULATION; ZAMBIA; HEALTH CARE DELIVERY; ODDS RATIO; OUTPATIENT DEPARTMENT; PROCEDURES; PROGRAM EVALUATION; TUBERCULOSIS, PULMONARY; WORLD HEALTH ORGANIZATION;

TUBERCULOSTATIC AGENT;

AMBULATORY CARE FACILITIES; ANTITUBERCULAR AGENTS; COMMUNITY HEALTH SERVICES; DELIVERY OF HEALTH CARE; DIRECTLY OBSERVED THERAPY; HUMANS; ODDS RATIO; PROGRAM EVALUATION; TUBERCULOSIS, PULMONARY; WORLD HEALTH ORGANIZATION;

EID: 84938981725     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-015-0945-5     Document Type: Article

References (57)

1. World Health Organization. Global Tuberculosis Report 2013. Geneva, Switzerland: World Health Organization; 2013.
2. World Health Organization. Global Plan to Stop TB 2011-2015. Geneva, Switzerland: World Health Organization; 2011.
3. Bayer R, Wilkinson D. Directly observed therapy for tuberculosis: history of an idea. Lancet. 1995;345(8964):1545-8.
4. Maher D, Floyd K, Sharma BV, Jaramillo E, Nkhoma W, Nyarko E, et al. Community contribution to TB care: practice and policy review of experience of community contribution to TB care and recommendations to national TB programs. Geneva, Switzerland: World Health Organization; 2003.
5. Khan MA, Walley JD, Witter SN, Shah SK, Javeed S. Tuberculosis patient adherence to direct observation: results of a social study in Pakistan. Health Policy Plan. 2005;20(6):354-65.
6. Khan MA, Walley JD, Witter SN, Imran A, Safdar N. Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Directly Observed Treatment. Health Policy Plan. 2002;17(2):178-86.
7. Datiko DG, Lindtjorn B. Cost and cost-effectiveness of smear-positive tuberculosis treatment by Health Extension Workers in Southern Ethiopia: a community randomized trial. PLoS One. 2010;5(2), e9158.
8. Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D. Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis. 2003;7(9 Suppl 1):S56-62.
9. Kangovi S, Mukherjee J, Bohmer R, Fitzmaurice G. A classification and meta-analysis of community-based directly observed therapy programs for tuberculosis treatment in developing countries. J Community Health. 2009;34(6):506-13.
10. Newell JN, Baral SC, Pande SB, Bam DS, Malla P. Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet. 2006;367(9514):903-9.
11. Wright J, Walley J, Philip A, Pushpananthan S, Dlamini E, Newell J, et al. Direct observation of treatment for tuberculosis: a randomized controlled trial of community health workers versus family members. Trop Med Int Health. 2004;9(5):559-65.
12. Walley JD, Khan MA, Newell JN, Khan MH. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet. 2001;357(9257):664-9.
13. Kamolratanakul P, Sawert H, Lertmaharit S, Kasetjaroen Y, Akksilp S, Tulaporn C, et al. Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand. Trans R Soc Trop Med Hyg. 1999;93(5):552-7.
14. Wandwalo E, Kapalata N, Egwaga S, Morkve O. Effectiveness of community-based directly observed treatment for tuberculosis in an urban setting in Tanzania: a randomised controlled trial. Int J Tuberc Lung Dis. 2004;8(10):1248-54.
15. Wandwalo E, Makundi E, Hasler T, Morkve O. Acceptability of community and health facility-based directly observed treatment of tuberculosis in Tanzanian urban setting. Health Policy. 2006;78(2-3):284-94.
16. Frieden TR, Sbarbaro JA. Promoting adherence to treatment for tuberculosis: the importance of direct observation. Bull World Health Organ. 2007;85(5):407-9.
17. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database of Syst Rev. 2007, Issue 4:CD003343.
18. Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M. A randomised controlled trial of lay health workers as direct observers for treatment of tuberculosis. Int J Tuberc Lung Dis. 2000;4(6):550-4.
19. Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet. 1998;352(9137):1340-3.
20. Lwilla F, Schellenberg D, Masanja H, Acosta C, Galindo C, Aponte J, et al. Evaluation of efficacy of community-based vs. institutional-based direct observed short-course treatment for the control of tuberculosis in Kilombero district, Tanzania. Trop Med and Int Health. 2003;8(3):204-10.
21. World Health Organization. Definitions and reporting framework for tuberculosis - 2013 version. Geneva, Switzerland: World Health Organization; 2013.
22. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
23. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60.
24. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-6.
25. Higgins JPT, Green S (editors). Cochrane handbook for systematic review of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011. http://handbook.cochrane.org . Accessed 20 August 2014.
26. Kironde S, Meintjies M. Tuberculosis treatment delivery in high burden settings: does patient choice of supervision matter? Int J Tuberc Lung Dis. 2002;6(7):599-608.
27. Miti S, Mfungwe V, Reijer P, Maher D. Integration of tuberculosis treatment in a community-based home care programme for persons living with HIV/AIDS in Ndola, Zambia. Int J Tuberc Lung Dis. 2003;7(9 Suppl 1):S92-8.
28. Niazi AD, Al-Delaimi AM. Impact of community participation on treatment outcomes and compliance of DOTS patients in Iraq. East Mediterr Health J. 2003;9(4):709-17.
29. Singh AA, Parasher D, Shekhavat GS, Sahu S, Wares DF, Granich R. Effectiveness of urban community volunteers in directly observed treatment of tuberculosis patients: a field report from Haryana, North India. Int J Tuberc Lung Dis. 2004;8(6):800-2.
30. Tripathy SK, Kumar P, Sagili KD, Enarson DA. Effectiveness of a community-based observation of anti-tuberculosis treatment in Bangalore City, India, 2010-2011. PHA. 2013;3(3):230-4.
31. Nirupa C, Sudha G, Santha T, Ponnuraja C, Fathima R, Chandrasekharan V, et al. Evaluation of directly observed treatment providers in the revised national tuberculosis control programme. Indian J Tuberc. 2005;52:73-7.
32. Maher D, Van Gorkom JLC, Gondrie PCFM, Raviglione M. Community contribution to tuberculosis care in countries with high tuberculosis prevalence: Past, present and future. Int J Tuberc Lung Dis. 1999;3(9):762-8.
33. Balasubramanian VN, Oommen K, Samuel R. DOT or not? Direct observation of anti-tuberculosis treatment and patient outcomes, Kerala State, India. Int J Tuberc Lung Dis. 2000;4(5):409-13.
34. Cavalcante SC, Soares ECC, Pacheco AGF, Chaisson RE, Durovni B, DOTS Expansion Team. Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model. Int J Tuberc Lung Dis. 2007;11(5):544-9.
35. Datiko DG, Lindtjorn B. Health extension workers improve tuberculosis case detection and treatment success in southern Ethiopia: a community randomized trial. PLoS One. 2009;4(5), e5443.
36. Egwaga S, Mkopi A, Range N, Haag-Arbenz V, Baraka A, Grewal P, et al. Patient-centred tuberculosis treatment delivery under programmatic conditions in Tanzania: a cohort study. BMC Med. 2009;7:80.
37. Ferreira V, Brito C, Portela M, Escosteguy C, Lima S. DOTS in primary care units in the city of Rio de Janeiro, Southeastern Brazil. Rev Saude Publica. 2011;45(1):40-8.
38. Kangangi JK, Kibuga D, Muli J, Maher D, Billo N, N'Gang'a L, et al. Decentralisation of tuberculosis treatment from the main hospitals to the peripheral health units and in the community within Machakos district, Kenya. Int J Tuberc Lung Dis. 2003;7(9 Suppl 1):S5-13.
39. Mafigiri DK, McGrath JW, Whalen CC. Task shifting for tuberculosis control: a qualitative study of community-based directly observed therapy in urban Uganda. Global Public Health. 2012;7(3):270-84.
40. Mahadev B, Kumar P, Sharada M. How effective are shopkeepers as DOT providers? A study under RNTCP in Bangalore Mahanagar Palike, Karnataka. Indian J Tuberc. 2006;53:18-26.
41. Mathema B, Pande SB, Jochem K, Houston RA, Smith I, Bam DS, et al. Tuberculosis treatment in nepal: a rapid assessment of government centers using different types of patient supervision. Int J Tuberc Lung Dis. 2001;5(10):912-9.
42. Pungrassami P, Chongsuvivatwong V. Are health personnel the best choice for directly observed treatment in southern Thailand? A comparison of treatment outcomes among different types of observers. Trans R Soc Trop Med Hyg. 2002;96(6):695-9.
43. Pungrassami P, Johnsen SP, Chongsuvivatwong V, Olsen J. Has directly observed treatment improved outcomes for patients with tuberculosis in southern Thailand? Trop Med Int Health. 2002;7(3):271-9.
44. van den Boogaard J, Lyimo R, Irongo CF, Boeree MJ, Schaalma H, Aarnoutse RE. Kibiki GS: Community vs. facility-based directly observed treatment for tuberculosis in Tanzania's Kilimanjaro Region. Int J Tuberc Lung Dis. 2009;13(12):1524-9.
45. Yassin MA, Datiko DG, Tulloch O, Markos P, Aschalew M, Shargie EB, et al. Innovative Community-Based Approaches Doubled Tuberculosis Case Notification and Improve Treatment Outcome in Southern Ethiopia. PLoS One. 2013;8(5), e63174.
46. Zvavamwe Z, Ehlers VJ. Experiences of a community-based tuberculosis treatment programme in Namibia: a comparative cohort study. Int J Nurs Stud. 2009;46(3):302-9.
47. Arora VK, Singla N, Gupta R. Community mediated domicillary DOTS execution: a study from New Delhi. Indian J Tuberc. 2003;50:143-50.
48. Bhagyalaxmi A, Jain S, Kadri AM. Effectiveness of Different Models of DOTS Providers under RNTCP in Ahmedabad City, Gujarat. Indian J Community Med. 2010;35(4):495-7.
49. Khieu K, Ito K, Hamajima N. Experience in tuberculosis treatment through directly observed therapy short course in health centres and communities in Cambodia. Public Health. 2007;121(9):696-9.
50. Mahyiuob Al-Honahi HY, Ohkado A, Masui T, Ali-Hussein IA, Saeed Al-Absi AN. A trial to mobilize NGO health volunteers to improve tuberculosis patient care in Sana'a City, Yemen. Kekkaku. 2010;85(3):159-62.
51. Lew W, Pai M, Oxlade O, Martin D, Menzies D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med. 2008;149(2):123-34.
52. Dudley L, Azevedo V, Grant R, Schoeman JH, Dikweni L, Maher D. Evaluation of community contribution to tuberculosis control in Cape Town, South Africa. Int J Tuberc Lung Dis. 2003;7(9 Suppl 1):S48-55.
53. Chowdhury AM, Chowdhury S, Islam MN, Islam A, Vaughan JP. Control of tuberculosis by community health workers in Bangladesh. Lancet. 1997;350(9084):1108.
54. Weiss P, Chen W, Cook VJ, Johnston JC. Treatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysis. BMC Infect Dis. 2014;14:333.
55. Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: A systematic review and meta-analysis. PLoS One. 2009;4(9), e6914.
56. Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. 2009;9(3):153-61.
57. Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, Bayona JN, et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med. 2012;9(8):e1001300.